{"cik":1671502,"taxonomy":"us-gaap","tag":"EarningsPerShareBasic","label":"Earnings Per Share, Basic","description":"The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.","entityName":"Quoin Pharmaceuticals, Ltd.","units":{"USD/shares":[{"start":"2019-01-01","end":"2019-12-31","val":-0.52,"accn":"0001104659-22-045620","fy":2021,"fp":"FY","form":"20-F","filed":"2022-04-14","frame":"CY2019"},{"start":"2020-01-01","end":"2020-12-31","val":-0.7,"accn":"0001104659-22-045620","fy":2021,"fp":"FY","form":"20-F","filed":"2022-04-14","frame":"CY2020"},{"start":"2021-01-01","end":"2021-12-31","val":-0.01,"accn":"0001104659-22-045620","fy":2021,"fp":"FY","form":"20-F","filed":"2022-04-14","frame":"CY2021"}]}}